• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Propylthiouracyl-Related Liver Toxicity; Public Workshop; April 18, 2009, Washington, D.C.

The Food and Drug Administration (FDA) is announcing a 1-day public workshop, cosponsored with the American Thyroid Association (ATA), entitled “Propylthiouracyl-Related Liver Toxicity.”  This public workshop is intended to provide a public forum for discussion of the clinical, scientific, and regulatory issues pertaining to Propylthiouracyl-induced hepatitis to seek constructive input from academia, regulatory scientists, and other interested parties on the topic of Propylthiouracyl-induced hepatitis.

 

Presentations [PDFs]

Date: April 18, 2009
Time: 8:00 a.m. - 3:30 p.m.
Location: The public workshop will be held at the Madison Hotel at 1177 15th St. N.W., Washington, D.C., 20005.

For map and directions visit: (http://www.loewshotels.com/en/Hotels/Washington-DC-Hotel/LocationInfo/Directions.aspx)

For meeting information, contact: Jeff O'Neill, telephone: (301) 796-0777 and fax: (301) 847-8753, email: jeff.o'neill@fda.hhs.gov